Bone marrow cells: Important role on neovascularization of hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 7, 2012, Pages 1241-1251

  Zhu, Haitao ^a,b   Shao, Qianwen ^b   Sun, Xitai ^a   Deng, Zhengming ^a   Yuan, Xianwen ^a   Zhou, Xiang ^a   Ding, Yitao ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow cells; Endothelial cells; Hepatocellular carcinoma; Vasculogenesis

Indexed keywords

CD133 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; PLATELET DERIVED GROWTH FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; LIVER CELL CARCINOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

EID: 84862687903     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07044.x     Document Type: Article

References (47)

1. Gao D, Mittal V. The role of bone marrow derived cells in tumor growth, metastasis initiation and progression. Trends Mol. Med. 2009; 15: 333-43.
2. Peichev M, Naiyer AJ, Pereira D etal. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-8.
3. Asahara T, Murohara T, Sullivan A etal. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
4. Miyamoto Y, Suyama T, Yashita T, Akimaru H, Kurata H. Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J. Mol. Cell. Cardiol. 2007; 43: 627-35.
5. Shaw JP, Basch R, Shamamian P. Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45. Blood Cells Mol. Dis. 2004; 32: 168-75.
6. Bai K, Huang Y, Jia X, Fan Y, Wang W. Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations. J. Biomech. 2010; 43: 1176-81.
7. Hamdan R, Zhou Z, Kleinerman ES. SDF-1{alpha} induces PDGF- B expression and the differentiation of bone marrow cells into pericytes. Mol. Cancer Res. 2011; 12: 1462-70.
8. Au P, Tam J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-8.
9. Santarelli JG, Udani V, Yung YC etal. Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 2006; 59: 374-82.
10. Pircher A, Kähler CM, Skvortsov S etal. Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance. Oncol. Rep. 2008; 19: 345-52.
11. Nolan DJ, Ciarrocchi A, Mellick AS etal. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 2007; 21: 1546-58.
12. Lyden D, Hattori K, Dias S, Costa C etal. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001; 7: 1194-201.
13. Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int. J. Cancer 2009; 125: 1771-7.
14. Purhonen S, Palm J, Rossi D etal. Bone marrow derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 6620-5.
15. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur. J. Cancer 2007; 43: 979-92.
16. Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J. Hepatol. 2009; 50: 604-20.
17. Fellner S, Reiberger T, Ulbrich G etal. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Dig. Liver Dis. 2009; 41: 902-6.
18. Ho JW, Pang RW, Lau C etal. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006; 44: 836-43.
19. Yu D, Sun X, Qiu Y etal. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin. Cancer Res. 2007; 13: 3814-24.
20. Schmitz V, Tirado-Ledo L, Tiemann K etal. Establishment of an orthotopic tumor model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice. J. Hepatol. 2004; 40: 787-91.
21. Murayama T, Tepper OM, Silver M etal. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp. Hematol. 2002; 30: 967-72.
22. Oren MT, Jennifer MC, Robert D etal. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005; 105: 1068-77.
23. Baba S, Fujii H, Hirose T etal. Commitment of bone marrow cells to hepatic stellate cells in mouse. J. Hepatol. 2004; 40: 255-60.
24. Strutz F, Okada H, Lo CW etal. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995; 130: 393-405.
25. Yoder MC, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim. Biophys. Acta 2009; 1796: 50-4.
26. Arbab AS, Pandit SD, Anderson SA etal. Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 2006; 24: 671-8.
27. Shirakawa K, Furuhata S, Watanabe I etal. Induction of vasculogenesis in breast cancer models. Br. J. Cancer 2002; 87: 1454-61.
28. Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am. J. Physiol. 1990; 258: 460-5.
29. Moon EJ, Jeong CH, Jeong JW etal. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1a. FASEB J. 2004; 18: 382-4.
30. Akiyoshi F, Sata M, Suzuki H etal. Serum vascular endothelial growth factor levels in various liver diseases. Dig. Dis. Sci. 1998; 43: 41-5.
31. Croll SD, Ransohoff RM, Cai N etal. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 2004; 187: 388-402.
32. Gehling UM, Ergun S, Schumacher U etal. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-12.
33. Moon MH, Kim SY, Kim YJ etal. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell. Physiol. Biochem. 2006; 17: 279-90.
34. O'Neill TJ IV, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ. Res. 2005; 97: 1027-35.
35. Hämmerling GJ, Ganss R. Vascular integration of endothelial progenitors during multistep tumor progression. Cell Cycle 2006; 5: 509-11.
36. Ryschich E, Schmidt J, Hammerling GJ, Klar E, Ganss R. Transformation of the microvascular system during multistage tumorigenesis. Int. J. Cancer 2002; 97: 719-25.
37. Ryschich E, Lizdenis P, Ittrich C etal. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. Cancer Res. 2006; 66: 198-211.
38. Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J. Hepatol. 2005; 42: 358-64.
39. Tanaka H, Yamamoto M, Hashimoto N etal. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 2006; 66: 11263-70.
40. Dahlke MH, Loi R, Warren A etal. Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells. J. Hepatol. 2006; 44: 334-41.
41. Ishikawa F, Shimazu H, Shultz LD etal. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J. 2006; 20: 950-2.
42. Xu H, Miki K, Ishibashi S etal. Transplantation of neuronal cells induced from human mesenchymal stem cells improves neurological functions after stroke without cell fusion. J. Neurosci. Res. 2010; 88: 3598-609.
43. Zech N. Plasticity of stem cells: cell-fusion versus transdifferentiation. J. Reproduktionsmed. Endokrinol. 2005; 2: 239-45.
44. Sueyoshi E, Hayashida T, Sakamoto I, Uetani M. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am. J. Roentgenol. 2010; 195: 245-51.
45. Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. Acta Radiol. 2008; 49: 523-9.
46. Shaked Y, Kerbel RS. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Res. 2007; 67: 7055-8.
47. Shaked Y, Henke E, Roodhart JM etal. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: imlpications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008; 14: 263-73.